KANTOFF AARON - Insider Non-Derivative Transactions at Tourmaline Bio, Inc. (TRML) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 28, 2025, KANTOFF AARON's relationship to Tourmaline Bio, Inc. (TRML) is Director, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRML insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

KANTOFF AARON - Insider Non-Derivative Transactions of TRML Common Stock

KANTOFF AARON - Insider Non-Derivative Transactions at TRML

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 29, 2025	U -- (Common Stock)	88281	0	0
Oct 25, 2025	G -- (Common Stock)	5000	0	88281
Sep 6, 2025	M -- (Common Stock)	37890	0.13	83281
Sep 6, 2025	M -- (Common Stock)	10000	9.46	93281
Oct 25, 2023	P -- (Common Stock)	7500	11.86	45391
Oct 20, 2023	Acquisition -- (Common Stock)	37891	0	37891